Skip to main content
SpringerLink
Log in

What can post market registries tell us about the use of cardiac resynchronization therapy?

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Cardiac resynchronization therapy (CRT) has become an established therapeutic option for patients with dilated cardiomyopathies and New York Heart Association class III congestive heart failure symptoms who also have a widened QRS complex on their electrocardiograms (generally > 120 ms). Results from a number of clinical trials have shown that CRT improves patients’ exercise tolerance, quality of life, and survival. There is further evidence that CRT has structural effects on the heart with improved cardiac function. Despite these salutary results, clinical trials in CRT study prespecified populations that fit the inclusion criteria for these trials. Many patients have been excluded from these clinical trials and yet may potentially benefit from CRT. Evaluation of the effects of CRT on these populations might reveal the potential to expand the use of this therapy in larger numbers of patients to CRT who may not have been included in the clinical trial. This review article will assess the limitations of some of the clinical trials in CRT and will discuss the potential for CRT registries that are presently underway to extend the patient population that may benefit from this therapeutic option.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Cleland JG, Khand A, Clark AL: The heart failure epidemic: exactly how big is it? Eur J Heart Fail 2001, 22:623–626.

    CAS  Google Scholar 

  2. American Heart Association: 2002 Heart and Stroke Statistical Update. Dallas: American Heart Association; 2001.

    Google Scholar 

  3. Hunt SA, Baker DW, Chin MH, et al.: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. J Am Coll Cardiol 2005, 46:1116–1143.

    Article  Google Scholar 

  4. MERIT HF Study Group: Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999, 353:2001–2007.

    Article  Google Scholar 

  5. Yu C-M, Chau E, Sanderson JE, et al.: Tissue Doppler echocardiographic evidence of reverse remodeling and improved chronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002, 105:438–445.

    Article  PubMed  Google Scholar 

  6. Xiao HB, Lee CH, Gibson DG: Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J 1991, 66:443–447.

    Article  PubMed  CAS  Google Scholar 

  7. Xiao HB, Brecker S, Gibson DG: Effects of abnormal activation on the time course of left ventricular pressure in dilated cardiomyopathy. Br Heart J 1992, 68:403–407.

    Article  PubMed  CAS  Google Scholar 

  8. Kass DA, Chen CH, Curry C, et al.: Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999, 99:1567–1573.

    PubMed  CAS  Google Scholar 

  9. Kerwin WF, Botvinick EH, O’Connel JW, et al.: Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 2000, 35:1221–1227.

    Article  PubMed  CAS  Google Scholar 

  10. Auricchio A, Stellbrink C, Sack S, et al.: Long-term effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002, 39:2026.

    Article  PubMed  Google Scholar 

  11. Stellbrink C, Auricchio A, Butler C, et al.: Pacing therapies in congestive heart failure II study. Am J Cardiol 2000, 86(Suppl):138K–143K.

    Article  PubMed  CAS  Google Scholar 

  12. Auricchio A, Stellbrink C, Sack S, et al.: For PATH-CHF Study Group. The pacing for congestive heart failure (PATH-CHF) study rationale, design and end-points of a prospective randomized multicenter study. Am J Cardiol 1999, 83(Suppl):130D–135D.

    Article  PubMed  CAS  Google Scholar 

  13. Cazeau S, Leclercq C, Lavergne T, et al.: The Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001, 344:873–880.

    Article  PubMed  CAS  Google Scholar 

  14. Abraham WT, Fisher WG, Smith AL, et al.: For the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845–1853.

    Article  PubMed  Google Scholar 

  15. Young JB, Abraham WT, Liem L, et al.: Cardiac resynchronization therapy (CRT) benefits patients with ICD indications-results of the InSync ICD Trial. Pacing Clin Electrophysiol 1002, 25:694.

    Google Scholar 

  16. Saxon LA, Boehmer JP, Hummel J, et al.: Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. Am J Cardiol 1999, 83:120D–123D.

    Article  PubMed  CAS  Google Scholar 

  17. Linde C, Leclerq C, Rex S, et al.: Long-term benefits of biventricular pacing in congestive heart failure: results from Multisite Stimulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002, 40:111–118.

    Article  PubMed  Google Scholar 

  18. Linde C, Braunschweig F, Gadler F, et al.: Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure; results from Multisite Stimulation in Cardiomyopathy (MUSTIC) Study. Am J Cardiol 2003, 91:1090–1095.

    Article  PubMed  Google Scholar 

  19. Saxon LA, De Marco T, Schafer J, et al.: For the VIGORCHF Investigators. Effects of chronic biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002, 105:1304–1310.

    Article  PubMed  Google Scholar 

  20. St. John Sutton MG, Plappert T, Abraham WT, et al.: For the Multicenter Insync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy in left ventricular size and function in chronic heart failure. Circulation 2003, 107:1985–1990.

    Article  PubMed  Google Scholar 

  21. Bristow MR, Saxon LA, Boehmer J, et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140–2150.

    Article  PubMed  CAS  Google Scholar 

  22. Cleland JG, Daubert JC, Erdmann E, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539–1549.

    Article  PubMed  CAS  Google Scholar 

  23. McAnulty HJ, Rahimtoola HS, Murphy E, et al.: Natural history of “high-risk’ bundle-branch block. N Engl J Med 1982, 307:137–143.

    Article  PubMed  CAS  Google Scholar 

  24. Shenkman HJ, McKinnon JE, Khandelwal AK, et al.: Determinants of QRS prolongation in a generalized heart failure population: findings from the Conquest Study [abstract]. Circulation 2000, 102(Suppl II).

  25. Schoeller R, Andersen D, Butner P, et al.: First or second-degree atrioventricular block as a risk factor in idiopathic dilated Cardiomyopathy. Am J Cardiol 1993, 71:720–726.

    Article  PubMed  CAS  Google Scholar 

  26. Aaronson KD, Schwartz JS, Chen TM, et al.: Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660–2667.

    PubMed  CAS  Google Scholar 

  27. Farwell D, Patel NR, Hall A, et al.: How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J 2000, 21:1247–1250.

    Article  Google Scholar 

  28. Shamin W, Francis DP, Yousufuddin M, et al.: Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999, 70:171–178.

    Article  Google Scholar 

  29. Baldasseroni S, Opasich C, Gorini M, et al.: Left bundlebranch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on Congestive Heart Failure. Am Heart J 2002, 143:398–405.

    Article  PubMed  Google Scholar 

  30. Auricchio AU, Klein HU: Beyond expectations: a decade of positive results with cardiac resynchronization therapy for heart failure. Eur Heart J Supplements 2002, 4(Suppl D):D95–D101.

    Google Scholar 

  31. Gasparini M et al.: Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry. Pacing Clin Electrophysiol 2006, 29(Suppl 2):S2–S10.

    Article  PubMed  Google Scholar 

  32. Eisen HJ: Interim report of RESTORE-US Registry. Presented at RESTORE-US Investigator Meeting. Orlando, FL; March 6, 2005.

  33. Abraham WT, Eisen HJ, Cohn JN: Cardiac resynchronization therapy is effective in patients with atrial fibrillation: interim results From the RESTORE-US Study. J Card Fail 2005, 11(6 Suppl):S89–S202.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Drexel University College of Medicine, 245 North 15th Street, Philadelphia, PA, 19102, USA

    Howard J. Eisen

Authors
  1. Howard J. Eisen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Howard J. Eisen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisen, H.J. What can post market registries tell us about the use of cardiac resynchronization therapy?. Curr Heart Fail Rep 4, 39–42 (2007). https://doi.org/10.1007/s11897-007-0024-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-007-0024-3

Keywords

Search

Navigation